new_adrs_0322_1315|ENFN|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_adrs_0322_1315|ENFN|1|Enfusion Inc Total Current Assets (Quarterly) (USD)|Enfusion Inc Cash and Short Term Investments (Quarterly) (USD)|Enfusion Inc Inventories (Quarterly) (USD)|Enfusion Inc Net PP&E (Quarterly) (USD)|Enfusion Inc Goodwill and Intangibles (Quarterly) (USD)|Enfusion Inc Total Liabilities (Quarterly) (USD)|Enfusion Inc Total Current Liabilities (Quarterly) (USD)|Enfusion Inc Total Long Term Liabilities (Quarterly) (USD)|Enfusion Inc Total Deposits (Quarterly) (USD)|Enfusion Inc Book Value (Quarterly) (USD)|Enfusion Inc Retained Earnings (Quarterly) (USD)|Enfusion Inc Treasury Stock (Quarterly) (USD)|Enfusion Inc EV to Revenues|Enfusion Inc EV to Earnings|Enfusion Inc EV to Free Cash Flow|Enfusion Inc EV to Assets (Quarterly)|Enfusion Inc PS Ratio|Enfusion Inc PE Ratio|Enfusion Inc Price to Book Value|Enfusion Inc PEG Ratio|Enfusion Inc Debt to Equity Ratio|Enfusion Inc Dividend Yield|Enfusion Inc Shareholder Yield (TTM)|Enfusion Inc Percent of Shares Outstanding Short|Enfusion Inc Total Receivables (Quarterly) (USD)|Enfusion Inc Total Payables (Quarterly) (USD)|Enfusion Inc Total Capital Stock (Quarterly) (USD)|Enfusion Inc Return on Invested Capital|Enfusion Inc Quality Ratio Score|Enfusion Inc Momentum Score|Enfusion Inc Beta (1Y)|Enfusion Inc Sustainable Growth Rate (TTM)|Enfusion Inc Institutional Investor Ownership Percentage|Enfusion Inc Average Diluted Shares Outstanding (Quarterly)|Enfusion Inc Total Employees (Annual)|Enfusion Inc EPS Diluted (Quarterly) (USD)|Enfusion Inc Shares Outstanding|Enfusion Inc Repurchase of Capital Stock (Quarterly) (USD)|Enfusion Inc Ordinary Shares Number (Quarterly)|Enfusion Inc Payout Ratio|Enfusion Inc Quick Ratio (Quarterly)|Enfusion Inc Normalized Diluted EPS (Quarterly) (USD)|Enfusion Inc Stock Buybacks (Quarterly) (USD)|Enfusion Inc Effective Tax Rate (TTM)|Enfusion Inc Return on Equity|Enfusion Inc Net Income (TTM) (USD)|Enfusion Inc Revenue (TTM) (USD)|Enfusion Inc Dividend Per Share (Quarterly) (USD)|Enfusion Inc Revenue (Quarterly) (USD)|Enfusion Inc Gross Profit (Quarterly) (USD)|Enfusion Inc SG&A Expense (Quarterly) (USD)|Enfusion Inc Pre-Tax Income (Quarterly) (USD)|Enfusion Inc Net Income (Quarterly) (USD)|Enfusion Inc Net Interest Income (Quarterly) (USD)|Enfusion Inc Price (USD)|Enfusion Inc Total Return Price (USD)|Enfusion Inc Enterprise Value (USD)|Enfusion Inc 30-Day Average Daily Volume|Enfusion Inc 1 Year Price Returns (Daily)||
new_adrs_0322_1315|ENFN|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_adrs_0322_1315|ENFN|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly||
new_adrs_0322_1315|ENFN|5|136.5|136.5||136.5||136.5|136.5|136.5||136.5|||||||||||273|1.45098039216||15.25|136.5|136.5|136.5||||||30|182.5|92|182.5|26||136.5||273|182.5|||||||182.5|182.5|182.5|182.5|182.5|182.5|1.45098039216|1.45098039216|1.45098039216|1.45205479452|||
new_adrs_0322_1315|ENFN|6|2|2||2||2|2|2||2|||||||||||1|102||8|2|2|2||||||4|2|1|2|2||2||1|2|||||||2|2|2|2|2|2|102|102|102|73|||
new_adrs_0322_1315|ENFN|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_adrs_0322_1315|ENFN|202009||||||||||||||||||||||||||||||||||64.0668||0.0871||||||0.0871|||||||19.785|14.392|8.219|5.808|5.58|-0.365|||||||
new_adrs_0322_1315|ENFN|202012|28.911|13.938||8.784||272.658|10.65|262.008||-233.559|||||||||||-0.422||||12.18|0.898|-233.347|||||||64.0668||-0.1902|||64.0668||2.4524|-0.1902|||||||22.66|16.502|28.423|-12.41|-12.187|-0.57|||||||
new_adrs_0322_1315|ENFN|202106|34.118|14.515||11.539||278.086|12.883|265.203||-230.883|||||||||||||||15.472|2.095|-230.594||||||||639||||64.0668||||||||||||||||||||||
new_adrs_0322_1315|ENFN|202109|35.508|8.432||12.498||279.266|16.277|262.989||-229.635|||||||||||-0.4247|||0.809|18.999|3.345|-229.329||||||10.3975|64.0668|798|0.0514|64.0668||64.0668||1.6853|0.0514|||||||29.045|20.95|16.047|3.447|3.293|-1.485|20.63|20.63|1410.8011|||19.36|
new_adrs_0322_1315|ENFN|202112||||||||||||||||||||||||1.77|||||||||56.3382||||65.5833||||||||||||||||||20.94|20.94|1462.4173|440484.2333||13.81|16.59
new_adrs_0322_1315|ENFN|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||15.43|15.43|1101.0533|295148.5333|||